Zimmer Biomet (ZBH) PT Raised to $160 at Cantor Fitzgerald
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $99.15 +0.97%
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Cantor Fitzgerald analyst Craig Bijou raised the price target on Zimmer Biomet (NYSE: ZBH) to $160.00 (from $150.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen (AMGN) PT Raised to $400 at Cantor Fitzgerald on Higher Sales Estimates
- Nebius Group (NBIS) PT Raised to $250 at DA Davidson
- Home Depot (HD) PT Lowered to $407 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
